| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0065 | 0.9 |